Dyadic to participate at Sanders Morris Harris Conf
21 Sep '05
1 min read
Biological products developer Dyadic International Inc announced that its President and CEO, Mark Emalfarb, would present at the Sanders Morris Harris Annual Investor Growth Conference to be held on September 23, 2005, at the Roosevelt Hotel, Madison Avenue at 45th Street, New York, NY.
Emalfarb's presentation is scheduled for 8:00 a.m. EDT and he will be available for the question and answer session as well as one-on-one meetings immediately following the presentation.
Dyadic International Inc is engaged in the development, manufacture and sale of biological products (proteins, enzymes, peptides and other bio-molecules), as well as the licensing of its enabling proprietary technology to business collaborators for the discovery, development and manufacture of biological products from genes.
Dyadic markets its products and services for applications in the textile, chemical, agricultural, pulp & paper, pharmaceutical, biotechnology and other industries, using its proprietary C1 Host Technology and C1 Expression and Screening Systems for the discovery, development and production of biological products.